TCF7L2 and metabolic syndrome: We assume that Tcf7l2 may predispose β cells to the risk of olanzapine-induced MetS, and a normal expression of Tcf7l2 can alleviate the negative effects of olanzapine and help the maintenance of proper pancreatic function and glucose homeostasis.